Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emil Johansson has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    COMBO ‐ RATE : An Experimentally Validated Bioinformatic Tool to Identify Promiscuous HLA Restrictions

    by Jessica Nevarez‐Mejia, Raphael Trevizani, Adam Abawi, Kendall Kearns, Emil Johansson, Aaron Sutherland, Alba Grifoni, Ricardo da Silva Antunes, Alessandro Sette

    Defining HLA restriction of T cell epitopes is essential for understanding immune responses in infectious disease, autoimmunity and vaccine design. Current bioinformatic programmes, including the IEDB RATE tool, enable inference of single‐HLA restrictions from immune response data of HLA‐typed donors. However, T cell epitopes are frequently presented by multiple HLA alleles, a phenomenon termed promiscuous restriction, limiting the utility of single‐allele approaches. To address this limitation, we developed COMBO‐RATE, an extension of RATE that systematically evaluates combinations of HLA alleles to identify multi‐allelic restriction patterns. Analysis of three independent datasets spanning distinct antigen systems and different epitope discovery strategies revealed that promiscuous restriction is a near‐universal feature of immunodominant epitopes. Focusing on the 43 immunodominant CD4 + T cell epitopes identified in a B. pertussis genome‐wide screen, COMBO‐RATE outperformed conventional RATE, identifying restrictions for 35 of 43 epitopes, compared to 24 by RATE alone, and uncovered 64 additional allele restrictions, including 29 unique alleles. Experimental validation using single‐HLA transfected cell lines and antigen presentation assays confirmed COMBO‐RATE‐inferred restrictions, demonstrating that a single epitope can be independently presented by distinct HLA alleles. Overall, COMBO‐RATE provides a robust and scalable framework for defining complete HLA restriction profiles from existing population response data, with important implications for the design of vaccines requiring broad HLA coverage across genetically diverse populations. This pipeline is available as both a Python package and a user‐friendly web application.

  • Open Access

    Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis

    by Tanner Michaelis, Cecilia S. Lindestam Arlehamn, Emil Johansson, April Frazier, Gregory P. Williams, James D. Berry, Merit Cudkowicz, Namita A. Goyal, Christina Fournier, Allison Snyder, et al.

  • Open Access

    Discordant outcomes of SARS-CoV-2 exposure in household contacts

    by Yeji Lee, Alison Tarke, Tertuliano Alves Pereira Neto, Emil Johansson, Benjamin Goodwin, Adam Abawi, April Frazier, Jennifer M. Dan, Shane Crotty, Alba Grifoni, et al.

  • Open Access

    Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis

    by Tanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, April Frazier, James D Berry, Merit Cudkowicz, Namita A Goyal, Christina Fournier, Allison Snyder, Justin Y Kwan, et al.

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a progressive loss of motor neurons. Neuroinflammation is apparent in affected tissues, including increased T cell infiltration and activation of microglia, particularly in the spinal cord1,2. Autoimmune responses are thought to have a key role in ALS pathology, and it is hypothesized that T cells contribute to the rapid loss of neurons during disease progression3,4. However, until now there has been no reported target for such an autoimmune response. Here we show that ALS is associated with recognition of the C9orf72 antigen, and we map the specific epitopes that are recognized. We show that these responses are mediated by CD4+ T cells that preferentially release IL-5 and IL-10, and that IL-10-mediated T cell responses are significantly greater in donors who have a longer predicted survival time. Our results reinforce the previous hypothesis that neuroinflammation has an important role in ALS disease progression, possibly because of a disrupted balance of inflammatory and counter-inflammatory T cell responses4. These findings highlight the potential of therapeutic strategies aimed at enhancing regulatory T cells5, and identify a key target for antigen-specific T cell responses that could enable precision therapeutics in ALS.


  • Open Access

    Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein

    by Antoine Freuchet, Emil Johansson, April Frazier, Irene Litvan, Jennifer G Goldman, Roy N Alcalay, David Sulzer, Cecilia S. Lindestam Arlehamn, Alessandro Sette

    Parkinson’s disease (PD) is a complex neurodegenerative disease with a largely unknown etiology. Although the loss of dopaminergic neurons in the substantia nigra pars compacta is the pathological hallmark of PD, neuroinflammation also plays a fundamental role in PD pathology. We have previously reported that PD patients have increased frequencies of T cell reactive to peptides from α -synuclein ( α -syn). However, not all PD participants respond to α -syn. Furthermore, we have previously found that CD4 T cells from PD participants responding to α -syn (PD_R) are transcriptionally distinct from PD participants not responding to α -syn (PD_NR). To gain further insight into the pathology of PD_R participants, we investigated surface protein expression of 11 proteins whose genes had previously been found to be differentially expressed when comparing PD_R and healthy control participants not responding to α -syn (HC_NR). We found that Cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2) was expressed on a significantly higher proportion of CD4 effector memory T cells (T EM ) in PD_R compared to HC_NR. Single-cell RNA sequencing analysis of cells expressing or not expressing CELSR2 revealed that PD_R participants have elevated frequencies of activated T EM subsets and an almost complete loss of cytotoxic T EM cells. Flow cytometry analyses confirmed that Granulysin + CD4 cytotoxic T EM cells are reduced in PD_R. Taken together, these results provide further insight into the perturbation of T cell subsets in PD_R, and highlights the need for further investigation into the role of Granulysin + CD4 cytotoxic T EM in PD pathology.

  • Open Access

    T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease

    by Emil Johansson, Antoine Freuchet, Gregory P. Williams, Tanner Michealis, April Frazier, Irene Litvan, Jennifer G Goldman, Roy N Alcalay, David G. Standaert, Amy W. Amara, et al.

    A role of the immune system in Parkinson’s disease (PD) progression has long been suspected due to the increased frequency of activated glial cells and infiltrating T cells into the substantia nigra. It was previously reported that PD donors have increased T cell responses towards PINK1 and α-synuclein (α-syn), two Lewy body-associated proteins. Further, T cell reactivity towards α-syn was highest closer to disease onset, highlighting that autoreactive T cells might play a role in PD pathogenesis. However, whether T cell autoreactivity is present during prodromal PD is unknown. Here, we investigated T cell responses towards PINK1 and α-syn in donors at high risk of developing PD (i.e. prodromal PD: genetic risk, hyposmia, and or REM sleep behavior disorder), in comparison to PD and healthy control donors. T cell reactivity to these two autoantigens was detected in prodromal PD at levels comparable to those detected in individuals with clinically diagnosed PD. Aligned with the increased incidence of PD in males, we found that males with PD, but not females, had elevated T cell reactivity compared to healthy controls. However, among prodromal PD donors, males and females had elevated T cell responses. These differing trends in reactivity highlights the need for further studies of the impact of biological sex on neuroinflammation and PD progression.


  • Open Access

    Chromium Next GEM Single Cell 3' HT Reagent Kits v3.1 (Dual Index) protocol v1

    by Emil Johansson

    This protocol has been adapted from the 10X User Guide CG000420, Rev D.

  • Open Access

    Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to ⍺-synuclein - CELSR2staining protocol v1

    by Antoine Freuchet, Emil Johansson, Cecilia Not Provided, Alessandro Sette

    The purpose of this protocol is to quantify the number of CD4 T cells expressing CELSR2.

  • Open Access

    Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to ⍺-synuclein - FACS of CELR2 expressing or non-expressing cells v1

    by Antoine Freuchet, Emil Johansson, Cecilia Not Provided, Alessandro Sette

    The purpose of this protocol is to sort CD4 Tem cells either expressing or not expressing CELSR2, to allow subsequent scRNAseq analysis.

  • Open Access

    Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to ⍺-synuclein - Cytotoxic panel staining v1

    by Antoine Freuchet, Emil Johansson, Cecilia Not Provided, Alessandro Sette

    The purpose of this protocol is to quantify the number of cytotoxic CD4 T cells in the different memory compartments